nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—AR—scrotum—malignant mesothelioma	0.632	0.632	CbGeAlD
Nilutamide—POR—decidua—malignant mesothelioma	0.08	0.08	CbGeAlD
Nilutamide—POR—lung—malignant mesothelioma	0.0538	0.0538	CbGeAlD
Nilutamide—POR—testis—malignant mesothelioma	0.0508	0.0508	CbGeAlD
Nilutamide—AR—epithelium—malignant mesothelioma	0.0501	0.0501	CbGeAlD
Nilutamide—AR—decidua—malignant mesothelioma	0.0473	0.0473	CbGeAlD
Nilutamide—AR—lung—malignant mesothelioma	0.0318	0.0318	CbGeAlD
Nilutamide—AR—testis—malignant mesothelioma	0.03	0.03	CbGeAlD
Nilutamide—CYP2C8—testis—malignant mesothelioma	0.0243	0.0243	CbGeAlD
